All Updates

All Updates

icon
Filter
Partnerships
GenEdit and Genentech collaborate to develop treatments for autoimmune disease
Human Gene Editing
Jan 23, 2024
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
Human Gene Editing

Human Gene Editing

Jan 23, 2024

GenEdit and Genentech collaborate to develop treatments for autoimmune disease

Partnerships

  • Gene drug developer GenEdit has entered a multi-year partnership with Genentech, a Roche Group member, to develop therapies for autoimmune diseases.

  • The partnership will leverage GenEdit's NanoGalaxy platform to develop hydrophilic nanoparticle (HNP) medications for autoimmune diseases. Genentech will take charge of preclinical, clinical, regulatory development, and product commercialization. GenEdit will receive an upfront payment of USD 15 million in advancements and milestone payments, along with royalties from global net sales. The potential financial payout for GenEdit could reach up to USD 629 million.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.